Loading…
Globus Medical, Inc. is projected to rise to $84.82 by 2027, a +9% move from its current price of $78.11. GMED is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/13/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 14 | $76.28 | $78.12 | $80.00 | +0.01% |
| Jul 15 | $75.53 | $78.13 | $80.81 | +0.02% |
| Jul 16 | $74.97 | $78.13 | $81.43 | +0.03% |
| Jul 17 | $74.50 | $78.14 | $81.96 | +0.04% |
| Jul 18 | $74.09 | $78.15 | $82.43 | +0.05% |
| Jul 19 | $73.72 | $78.16 | $82.86 | +0.06% |
| Jul 20 | $73.39 | $78.17 | $83.26 | +0.07% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $73.39 | $78.17 | $83.26 | +0.07% |
| Week 2 | $71.54 | $78.22 | $85.53 | +0.15% |
| Week 3 | $70.17 | $78.28 | $87.33 | +0.22% |
| Week 4 | $69.05 | $78.34 | $88.88 | +0.29% |
| Week 5 | $68.08 | $78.40 | $90.28 | +0.37% |
| Week 6 | $67.21 | $78.45 | $91.57 | +0.44% |
| Week 7 | $66.43 | $78.51 | $92.78 | +0.51% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products comprising traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices; treatment options for motion preservation technologies consisting of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and biologic solutions, such as allografts and synthetic alternatives.
It also provides orthopedic trauma solutions, including limb reconstruction, fracture plating, intramedullary nailing, external fixation, and compression screw technologies; hip and knee arthroplasty solutions, including modular cement and cementless hip stems, acetabular cups, femoral heads, highly cross-linked liners, partial knee systems, cruciate retaining, posterior stabilized, and revision options; spinal cord stimulation services; and neuromonitoring services, which provide onsite and remote monitoring of the neurological systems. It also offers ExcelsiusGPS platform, a robotic guidance and navigation system for minimally invasive and open procedures; Surgimap, a surgical planning software platform; Excelsius3D, a platform combined with ExcelsiusGPS that provides an intraoperative and image-guided robotic navigation solution; ExcelsiusHub, which provides real-time patient array monitoring, tissue sparing drills, and registration flexibility; and ExcelsiusFlex, a total knee arthroplasty robotic solution. Further, it distributes human cells, tissues, and cellular and tissue-based products.
The company sells its products through direct and distributor sales representatives; and independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
Globus Medical, Inc. (GMED) is a healthcare company focused on musculoskeletal solutions. The stock is currently priced at $75.96 with a market capitalization of $10.31B, and it is ranked 916 by market size.
The current price and market position place GMED among mid-cap healthcare peers. The forecast implies a multi-year upside, with the average price advancing notably in later years and rising ROIs, culminating in substantial upside by 2050.
A major floor 11.5% below — a decisive break under it would weaken the trend.
The nearest floor, 3.4% below — buyers have tended to step in here.
The nearest ceiling, 10.4% above — a clean break opens room to run.
A major ceiling 24.0% above — clearing it would confirm fresh momentum.
Key GMED support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of GMED market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $78.06 | Buy | $77.98 | Buy |
| MA 10 | $79.56 | Sell | $78.77 | Sell |
| MA 20 | $79.60 | Sell | $79.56 | Sell |
| MA 50 | $81.17 | Sell | $81.63 | Sell |
| MA 100 | $85.68 | Sell | $83.09 | Sell |
| MA 200 | $82.43 | Sell | $81.32 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 46.05 | Neutral |
| Stoch RSI (14) | 27.76 | Neutral |
| CCI (20) | -44.79 | Neutral |
| Williams %R (14) | -79.11 | Info |
| MACD (12,26,9) | -0.26 | Sell |
| ROC (12) | -2.41 | Sell |
| Bollinger %B (20,2) | 0.37 | Neutral |
| Stochastic %K (14) | 20.89 | Neutral |
| TRIX (15) | -0.12 | Sell |
| Awesome (5,34) | -2.27 | Sell |
| Ultimate (7,14,28) | 47.04 | Neutral |
| Momentum (10) | -6.54 | Sell |
| Aroon Osc (25) | 24.00 | Buy |
| Hull MA (9) | 76.58 | Buy |
| ADX (14) | 12.88 | Neutral |
| ATR (14) | 1.87 | Info |
Technical picture for the next 30 days remains NEUTRAL. RSI(14) is 40, with the stock trading near its short- and intermediate-term averages. The SMA50 is $83.01 and the SMA200 is $81.78, suggesting price action around the vicinity of these moving averages.
Immediate support is at $75.42 and resistance at $86.25, framing a near-term range that aligns with the 30-day window of $64.70 to $89.18.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $75.42 | $78.11 | $98.67 | 0% | Neutral | |
| $68.32 | $84.82 | $110.90 | +9% | Neutral | |
| $68.10 | $86.60 | $117.01 | +11% | Neutral | |
| $75.24 | $97.60 | $135.33 | +25% | Bullish | |
| $86.81 | $114.60 | $162.39 | +47% | Bullish | |
| $96.46 | $129.38 | $186.87 | +66% | Bullish | |
| $102.61 | $139.68 | $205.23 | +79% | Bullish | |
| $106.05 | $146.36 | $218.42 | +87% | Bullish | |
| $111.02 | $155.23 | $235.01 | +99% | Bullish | |
| $110.12 | $155.91 | $239.20 | +100% | Bullish | |
| $163.03 | $244.19 | $396.23 | +213% | Bullish | |
| $264.91 | $436.54 | $768.99 | +459% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $75.42 | $78.11 | $93.27 | +0.00% |
| August 2026 | $66.14 | $77.78 | $93.71 | -0.42% |
| September 2026 | $66.65 | $78.86 | $95.96 | +1.39% |
| October 2026 | $68.39 | $81.34 | $99.81 | +3.15% |
| November 2026 | $67.78 | $80.99 | $100.06 | -0.44% |
| December 2026 | $66.14 | $79.35 | $98.67 | -2.02% |
Click any year to see its month-by-month GMED forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Globus Medical, Inc.'s 2026 outlook centres on $78.11, within a $75.42 to $98.67 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, GMED could reach as high as $110.90, with a base case around $84.82 and support toward $68.32 — roughly +9% from $78.11. A consolidation phase looks the most probable path here.
Expect GMED to range from $68.10 to $117.01 through 2028. The $86.60 average target implies a +11% move from current prices. That is up +2% on the projected 2027 average. Price action looks broadly range-bound.
The GMED price prediction for 2029 points to an average of $97.60 (low $75.24, high $135.33) — a potential gain of +25% on today's $78.11. Buyers look set to stay in control over this stretch.
In 2030, GMED is projected to trade between $86.81 and $162.39, averaging $114.60 — a potential gain of +47% from today's $78.11. That is up +17% on the projected 2029 average. Momentum favours further upside here.
Globus Medical, Inc.'s 2031 outlook centres on $129.38, within a $96.46 to $186.87 range. That is up +13% on the projected 2030 average. That marks a +66% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, GMED could reach as high as $205.23, with a base case around $139.68 and support toward $102.61 — roughly +79% from $78.11. Momentum favours further upside here.
Expect GMED to range from $106.05 to $218.42 through 2033. The $146.36 average target implies a +87% move from current prices. That is up +5% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The GMED price prediction for 2034 points to an average of $155.23 (low $111.02, high $235.01) — a potential gain of +99% on today's $78.11. Momentum favours further upside here.
In 2035, GMED is projected to trade between $110.12 and $239.20, averaging $155.91 — a potential gain of +100% from today's $78.11. That is up 0% on the projected 2034 average. Buyers look set to stay in control over this stretch.
Globus Medical, Inc.'s 2040 outlook centres on $244.19, within a $163.03 to $396.23 range. That is up +57% on the projected 2035 average. That marks a +213% change versus current levels. Momentum favours further upside here.
By 2050, GMED could reach as high as $768.99, with a base case around $436.54 and support toward $264.91 — roughly +459% from $78.11. Buyers look set to stay in control over this stretch.
Investing $1,000 in GMED today (≈ 12.802458 GMED) could be worth
$5,588.83
+$4,588.83 (+459%) by 2050 · US Dollar
Based on the average projected GMED price of $436.54 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in GMEDwould be worth at today's price.
$1,000 invested in GMED on Jul 10, 2025 (≈ 17.301038 GMED) would be worth
$1,351.38
+$351.38 (+35.1%) today · 1.35× · US Dollar
Based on a GMED entry price of $57.8 vs. today's $78.11.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $80.12 | $974.91 | -2.5% |
| 1 month ago | $80.86 | $965.99 | -3.4% |
| 3 months ago | $90.42 | $863.86 | -13.6% |
| 6 months ago | $91.72 | $851.61 | -14.8% |
| 1 year ago | $57.8 | $1,351.38 | +35.1% |
| All time (5.0y) ago | $79.18 | $986.49 | -1.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our GMED forecast.
Our base-case forecast reaches $160.00 around 2040.
Implied market cap at $160.00: $18.13B
The multi-year forecast shows a path from neutral to bullish sentiment beginning in 2029, with the average price rising from $95.39 in 2029 to $112.63 in 2030 and then climbing further through 2040 and 2050. Specifically, the 2030 average is $112.63 with a 48.3% ROI and bullish sentiment; 2040 carries an average of $235.67 with a 210.3% ROI, and 2050 projects an average of $425.42 with a 460.1% ROI, all indicating a strong bullish trajectory over the longer term. Earlier years are shown as neutral or modestly positive (2026 min $75.42, avg $75.96, max $96.20; 2027 avg $83.01 with 9.3% ROI; 2028 avg $83.41 with 9.8% ROI).
The forecast implies sustained upside potential through 2030, 2040, and 2050, albeit as estimates with inherent uncertainty and no guarantees.
Tap a question to reveal the answer.
2030 avg $112.63; min $85.03; max $160.28; ROI 48.3%; sentiment BULLISH.
The forecast suggests a neutral stance in the early years (2026–2028) followed by a bullish trajectory from 2029 onward, with averages rising to $112.63 by 2030 and to $425.42 by 2050 and ROIs up to 460.1%. These are estimates and not guarantees.
Yes, based on the forecast, the max values exceed $200 in later years, with 2032 max $201.75 and 2033 max $215.45, among others.
Current price is $75.96 and market cap is $10.31B.
The 30-day range is $64.70 to $89.18. RSI(14) is 40, SMA50 is $83.01, SMA200 is $81.78, and annualized volatility is 50%.
Globus Medical, Inc. Community Discussion
0Share your Globus Medical, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.